Sunstone Life Science
Ventures Fund III
Sunstone Life Science Fund III K/S focusses on Danish, Nordic and European seed and start-up companies within biotech, medtech and diagnostics. Sunstone LSV Fund III is managed by the venture company Sunstone Capital that focusses on developing and expanding early stage technology and life science companies. The new fund, Sunstone Life Science Ventures Fund III K/S, increases Sunstone Capital’s assets under management to over DKK five billion. |
FACTS ABOUT SUNSTONE LIFE SCIENCE VENTURES FUND III K/S
CAPITAL COMMITMENT FROM DANSK VÆKSTKAPITAL
DKK 200m
FUND SIZE
DKK 662m
DANSK VÆKSTKAPITAL’S EQUITY INTEREST
30.2 %
INVESTMENT DATE
16 December 2011